ArticleRSC advances2025

Discovery of new benzothiazole-1,2,3-triazole hybrid-based hydrazone/thiosemicarbazone derivatives as potent EGFR inhibitors with cytotoxicity against cancer.

Ateyatallah Aljuhani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.